Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer

被引：0
|
作者：
Andreas Ihrig
Pascal Marino Pernt
Stefanie Zschäbitz
Johannes Huber
Hans-Christoph Friederich
Till J. Bugaj
Imad Maatouk
机构：
[1] University Hospital Heidelberg,Division of Psycho
[2] National Centre for Tumor Diseases (NCT),Oncology, Department of General Internal Medicine and Psychosomatics
[3] University Hospital Heidelberg,Department of Medical Oncology
[4] Philipps-University Marburg,Department of Urology
[5] Julius-Maximilian University Würzburg,Section of Psychosomatic Medicine, Psychotherapy and Psycho
来源：
International Urology and Nephrology | 2023年 / 55卷
关键词：
Metastatic prostate cancer; Hormonal agents; Androgen deprivation therapy; Neurocognitive effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2733 / 2739
页数：6
相关论文
共 50 条
  • [11] Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer
    Borno, Hale T.
    Lichtensztajn, Daphne Y.
    Gomez, Scarlett L.
    Palmer, Nynikka R.
    Ryan, Charles J.
    CANCER, 2019, 125 (03) : 453 - 462
  • [12] Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer
    Planas, Jacques
    Celma, Ana
    Placer, Jose
    Cuadras, Merce
    Regis, Lucas
    Gasanz, Carlos
    Trilla, Enrique
    Salvador, Carlos
    Lorente, David
    Morote, Juan
    SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (06) : 425 - 428
  • [13] Cardiometabolic side effects of androgen deprivation therapy in prostate cancer
    Lafontaine, Marie-Lyssa
    Kokorovic, Andrea
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 216 - 222
  • [14] Androgen deprivation therapy for prostate cancer:: Effects on hand function
    Soyupek, Feray
    Soyupek, Sedat
    Perk, Hakki
    Ozorak, Alper
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (02) : 141 - 146
  • [15] Androgen deprivation therapy and the risk of tenosynovitis in prostate cancer patients
    Jui-Ming Liu
    Dai-Wei Liu
    Heng-Chang Chuang
    Chun-Te Wu
    Chien-Yu Lin
    Ren-Jun Hsu
    International Urology and Nephrology, 2019, 51 : 1113 - 1119
  • [16] Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer
    Jonathan Assayag
    Hui Yin
    Serge Benayoun
    Michael N. Pollak
    Samy Suissa
    Laurent Azoulay
    Cancer Causes & Control, 2013, 24 : 839 - 845
  • [17] Maintaining intimacy for prostate cancer patients on androgen deprivation therapy
    Wassersug, Richard J.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2016, 10 (01) : 55 - 65
  • [18] Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer
    Assayag, Jonathan
    Yin, Hui
    Benayoun, Serge
    Pollak, Michael N.
    Suissa, Samy
    Azoulay, Laurent
    CANCER CAUSES & CONTROL, 2013, 24 (05) : 839 - 845
  • [19] Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: A retrospective chart review
    Curtis, Kelly K.
    Adam, Terrence J.
    Chen, Shu-Chuan
    Pruthi, Rajiv K.
    Gornet, Michael K.
    AGING MALE, 2008, 11 (04) : 157 - 161
  • [20] Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications
    Tzortzis, Vasileios
    Samarinas, Michael
    Zachos, Ioannis
    Oeconomou, Athanasios
    Pisters, Louis L.
    Bargiota, Alexandra
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2017, 16 (02): : 115 - 123
12345